A detailed history of Peak Financial Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Peak Financial Management, Inc. holds 418 shares of LLY stock, worth $369,708. This represents 0.12% of its overall portfolio holdings.

Number of Shares
418
Previous 653 35.99%
Holding current value
$369,708
Previous $508,000 25.59%
% of portfolio
0.12%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$724.87 - $909.04 $170,344 - $213,624
-235 Reduced 35.99%
418 $378,000
Q1 2024

Apr 22, 2024

BUY
$592.2 - $792.28 $155,748 - $208,369
263 Added 67.44%
653 $508,000
Q4 2023

Jan 18, 2024

BUY
$525.19 - $619.13 $204,824 - $241,460
390 New
390 $227,000
Q2 2023

Jul 26, 2023

BUY
$350.74 - $468.98 $204,832 - $273,884
584 New
584 $273,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $840B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Peak Financial Management, Inc. Portfolio

Follow Peak Financial Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Peak Financial Management, Inc. with notifications on news.